Outcome of double-filtration plasmapheresis plus interferon treatment in nonresponders to pegylated interferon plus ribavirin combination therapy.

Kayo Sugimoto,Soo Ryang Kim,Ahmed El-Shamy,Susumu Imoto,Haruma Fujioka,Ke Ih Kim,Yasuhito Tanaka,Yoshihiko Yano,Soo Ki Kim,Yutaka Hasegawa,Aya Fujinami,Mitsuhiro Ohta,Takashi Hatae,Hak Hotta,Yoshitake Hayashi,Masatoshi Kudo

Outcome of double-filtration plasmapheresis plus interferon treatment in nonresponders to pegylated interferon plus ribavirin combination therapy.

2013

Kayo Sugimoto
Soo Ryang Kim
Ahmed El-Shamy
Susumu Imoto
Haruma Fujioka
Ke Ih Kim
Yasuhito Tanaka
Yoshihiko Yano
Soo Ki Kim
Yutaka Hasegawa
Aya Fujinami
Mitsuhiro Ohta
Takashi Hatae
Hak Hotta
Yoshitake Hayashi
Masatoshi Kudo

Objectives: We assessed the outcome of double-filtration plasmapheresis (DFPP) combined with pegylated interferon (PEG-IFN) and ribavirin (RBV) therapy in patient

Keywords:

Plasmapheresis
Ribavirin
Interferon
Combination therapy
Medicine
Pegylated interferon
Diabetes mellitus
Gastroenterology
in patient
double filtration plasmapheresis
General surgery
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations